Fantastic transparent update, a few highlights:
- Revenues for FY20 in excess of $5 million and Cash of over $27 million. Further significant additional cash receipts from sales made during the quarter expected to be received this quarter.
- NG Biotech committing to the purchase of more than 1.75m devices during the quarter (an increase of 250K units)
- Discussions are well progressed for potential COVID-19 partnerships for distribution into other markets, including North America.
- Doubling of capacity to 500,000 units per month this quarter, on track to manufacture 1 million per month by the end of the year
The question is not of demand, its of supply and if they are able to achieve anywhere near 12 million units per quarter x assuming a $10 blended average cost per device would be significant revenue for Atomo and likely demanding a market cap well over $1.
I will be looking to add on any major weakness in the share price.
- Forums
- ASX - By Stock
- AT1
- Ann: Quarterly Activity Report & Appendix 4C - 30 June 2020
Ann: Quarterly Activity Report & Appendix 4C - 30 June 2020, page-18
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.89M |
Open | High | Low | Value | Volume |
2.7¢ | 2.8¢ | 2.5¢ | $3.866K | 140.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 472951 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 143054 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 472951 | 0.025 |
2 | 617050 | 0.024 |
3 | 893000 | 0.023 |
7 | 604373 | 0.022 |
4 | 432292 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 143054 | 2 |
0.029 | 452248 | 7 |
0.030 | 419488 | 7 |
0.031 | 196496 | 4 |
0.033 | 367586 | 3 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |